Eventum Orthopaedics

Executive Summary

Eventum Orthopaedics is a UK-based medical device company addressing the high dissatisfaction rates in total knee arthroplasty (TKA) through its proprietary Quadsense system. Quadsense provides real-time intraoperative data on patellofemoral joint loads, enabling surgeons to make more informed decisions during joint replacement surgery. Founded in 2020, the company is positioning itself as a leader in orthopaedic innovation by targeting a critical unmet need: improving patient outcomes and reducing revision surgeries. The global knee replacement market is valued at over $10 billion, with dissatisfaction rates as high as 20%, representing a significant commercial opportunity. Eventum's technology has the potential to become standard-of-care by offering objective, real-time feedback that currently lacks in TKA procedures. The company is privately held and has not disclosed funding or valuation details, but its focused approach and experienced team validate its potential. With upcoming regulatory milestones and clinical validations, Eventum Orthopaedics is poised for growth.

Upcoming Catalysts (preview)

• Q1 2027CE Mark Approval for Quadsense70% success
• Q4 2026Publication of First Clinical Study Results65% success
• Q2 2027Strategic Partnership with a Major Orthopaedic Implant Manufacturer40% success